OMP-52M51
OMP-52M51 Uses, Dosage, Side Effects, Food Interaction and all others data.
OMP-52M51 has been used in trials studying the treatment of Adenoid Cystic Carcinoma, Relapsed or Refractory Solid Tumors, and Relapsed or Refractory Lymphoid Malignancies.
Trade Name | OMP-52M51 |
Generic | Brontictuzumab |
Brontictuzumab Other Names | Brontictuzumab, OMP-52M51 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here OMP-52M51